Medicare Enrolled

Dr. Angelita Beredo, M.D.

Endocrinology · Inglewood, CA
Practice pattern: Clinical Cardiology — Primarily office-based clinical cardiology
Low-engagement
323 N PRAIRIE AVE, Inglewood, CA 90301
3106712699
In practice since 2007 (18 years)
NPI: 1619158318 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Beredo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Beredo? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Beredo

Dr. Angelita Beredo is an endocrinology specialist in Inglewood, CA, with 18 years of NPI registration. Based on federal Medicare data, Dr. Beredo performed 1,961 Medicare services across 888 unique beneficiaries.

Between the years covered by Open Payments, Dr. Beredo received a total of $13,469 from 42 pharmaceutical and/or device companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Beredo is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 18 years in practice ▲ Top 30% volume in CA $13,469 industry payments

Medicare Practice Summary

Medicare Utilization ↗
1,961
Medicare services
Top 30% in CA for endocrinology
888
Unique beneficiaries
$58
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~109 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
687 $108 $160
Blood glucose test using hand-held instrument
A test that measures the level of sugar in the blood using a portable device. The result helps monitor blood glucose levels.
468 $3 $25
Blood draw (venipuncture)
Insertion of a needle into a vein to collect a blood sample.
421 $8 $25
Annual wellness visit, follow-up
A follow-up annual wellness visit that includes a personalized prevention plan of service.
121 $141 $150
Hospital follow-up visit, moderate complexity
Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service.
77 $66 $200
Urinalysis, manual
A manual laboratory examination of a urine sample to check for various substances and cells.
71 $3 $25
Influenza vaccine, quadrivalent, 0.5 ml dosage 29 $20 $60
Flu vaccine administration
This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient.
29 $33 $60
New patient office visit, complex (60-74 min) 24 $188 $350
Initial hospital admission, high complexity
Initial hospital inpatient or observation care for a new patient involving high-level medical decision making, with at least 75 minutes total time on the date of the encounter.
19 $146 $375
Office visit, established patient, complex (40-54 min)
An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter.
15 $144 $200
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$13,469
Total received (2018-2024)
Avg $1,924/year across 7 years
Top 16% in CA for endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
42
Companies
632
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,469 (100.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$1,742
2023
$2,334
2022
$2,280
2021
$2,416
2020
$1,629
2019
$1,346
2018
$1,722

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Lilly USA, LLC
$275
Novo Nordisk Inc
$238
Dexcom, Inc.
$208
Mannkind Corporation
$197
Bayer Healthcare Pharmaceuticals Inc.
$175
Amgen Inc.
$157
Boehringer Ingelheim Pharmaceuticals, Inc.
$130
Abbott Laboratories
$112
AstraZeneca Pharmaceuticals LP
$84
Ascensia Diabetes Care Us Inc.
$82
Otsuka America Pharmaceutical, Inc.
$46
Esperion Therapeutics, Inc.
$24
CeQur Corporation
$15
Top 3 companies account for 41.4% of 2024 payments
All-time payments by company (2018-2024) ›
AstraZeneca Pharmaceuticals LP
$2,369
Lilly USA, LLC
$1,834
Novo Nordisk Inc
$1,099
SANOFI-AVENTIS U.S. LLC
$973
Insulet Corporation
$765
Boehringer Ingelheim Pharmaceuticals, Inc.
$752
Dexcom, Inc.
$568
Mannkind Corporation
$546
Bayer Healthcare Pharmaceuticals Inc.
$405
Zealand Pharma US, Inc.
$392
Amgen Inc.
$381
Amarin Pharma Inc.
$356
MannKind Corporation
$355
Bayer HealthCare Pharmaceuticals Inc.
$346
Abbott Laboratories
$325
Novartis Pharmaceuticals Corporation
$308
ABBVIE INC.
$195
Janssen Pharmaceuticals, Inc
$169
IBSA Pharma Inc.
$156
Horizon Therapeutics plc
$137
ARBOR PHARMACEUTICALS, INC.
$113
Endo Pharmaceuticals Inc.
$87
Xeris Pharmaceuticals, Inc.
$85
Ascensia Diabetes Care Us Inc.
$82
Merck Sharp & Dohme Corporation
$79
Esperion Therapeutics, Inc.
$65
Arbor Pharmaceuticals, Inc.
$59
AbbVie Inc.
$57
Valeritas, Inc.
$55
Ascensia Diabetes Care US Inc.
$48
Otsuka America Pharmaceutical, Inc.
$46
Medtronic, Inc.
$39
DEXCOM, INC.
$28
CeQur Corporation
$27
Regeneron Healthcare Solutions, Inc.
$25
Shire North American Group Inc
$25
Corcept Therapeutics
$23
Allergan Inc.
$23
Takeda Pharmaceuticals U.S.A., Inc.
$23
Synergy Pharmaceuticals Inc
$22
Biohaven Pharmaceuticals, Inc.
$15
GlaxoSmithKline, LLC.
$12
Top 3 companies account for 39.4% of all-time payments
Associated products mentioned in payments ›
AFREZZA · Amitiza · BAQSIMI · BYDUREON · CeQur Simplicity · Contour Next · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · ENTRESTO · EVENITY · EVERSENSE 365 SENSOR KIT (RETAIL) · EVERSENSE E3 SENSOR KIT - RETAIL · Edarbi · FARXIGA · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · FreeStyle Libre · FreeStyle Libre blood glucose Flash Monitoring System · GVOKE HYPOPEN · GVOKE PFS · HUMALOG · HUMULIN · HUMULIN R 500 · Horizant · INPEN SMART INSULIN DELIVERY SYSTEM · INVOKANA · JANUVIA · JARDIANCE · Kerendia · Korlym · LEQVIO · LICART · MOUNJARO · NASCOBAL · NATPARA · NEXLETOL · NURTEC ODT · Omnipod · Ozempic · PRALUENT · PRALUENT ALIROCUMAB INJECTION · QULIPTA · REXULTI · RYBELSUS · Repatha · Rybelsus · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SYNJARDY · SYNTHROID · TEPEZZA · TOUJEO · TRADJENTA · TRULICITY · Tirosint · Tresiba · Trulance · UBRELVY · V-GO · V-GO DISPOSABLE INSULIN DELIVERY · VIBERZI · VRAYLAR · Vascepa · Victoza · Wegovy · XARELTO · ZEGALOGUE
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Looking for an endocrinology specialist in Inglewood?
Compare endocrinologists in the Inglewood area by procedure volume, costs, and industry payment transparency.
Browse endocrinologists nearby

Geographic Context

Endocrinologists within 10 mi
264
Per 100K population
2.7
County median income
$87,760
Nearest hospital
CENTINELA HOSPITAL MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Beredo is a clinical cardiology specialist, with above-average Medicare volume (top 30% in CA), with low-engagement industry engagement in the top 16% of CA peers, with 18 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Beredo experienced with office visit, established patient (30-39 min)?
Based on Medicare claims data, Dr. Beredo performed 687 office visit, established patient (30-39 min) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Beredo receive payments from pharmaceutical companies?
Yes. Dr. Beredo received a total of $13,469 from 42 companies across 632 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Beredo's costs compare to other endocrinologists in Inglewood?
Dr. Beredo's average Medicare payment per service is $58. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Beredo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →